Back to KI Korea Investment CORP
ALXN12 quarters
Position history for KIKorea Investment CORP's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Korea Investment held 45,500 shares of ALXN (Alexion Pharmaceuticals), worth $8.4M. Korea Investment's 13F filings listed ALXN from Q4 2018 to Q2 2021, 11 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$14.5M
Total Shares Change
-149,002
Quarter-by-Quarter History
Other major holders of ALXN: FMR LLC, STATE STREET CORP